Advertisement
Screener

NOVAVAX INC (NVAX) Interest Expense

NOVAVAX INC Interest Expense

NOVAVAX INC (NVAX) reported Interest Expense of $4.11 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-10.

Discontinued › Expense Statement

us-gaap:InterestExpense · last filed 2024-05-10

  • NOVAVAX INC interest expense for the quarter ending 2024-03-31 was $4.11M, a 4.75% decline year-over-year.
  • NOVAVAX INC interest expense for the quarter ending 2023-12-31 was $4.12M, a 10.52% decline year-over-year.
  • NOVAVAX INC interest expense for the quarter ending 2023-09-30 was $2.86M, a 31.42% decline year-over-year.
  • NOVAVAX INC interest expense for the quarter ending 2023-06-30 was $3.12M, a 49.89% decline year-over-year.
  • NOVAVAX INC interest expense for fiscal 2023 was $14.42M, a 27.48% decline from fiscal 2022.
  • NOVAVAX INC interest expense for fiscal 2022 was $19.88M, a 5.90% decline from fiscal 2021.
  • NOVAVAX INC interest expense for fiscal 2021 was $21.13M, a 39.50% increase from fiscal 2020.
  • NOVAVAX INC interest expense for fiscal 2020 was $15.14M, a 11.26% increase from fiscal 2019.
Period endInterest Expense 3 monthInterest Expense 6 monthInterest Expense 9 monthInterest Expense 12 month
2024-03-31$4.11M
10-Q · filed 2024-05-10
$8.23M
derived: sum of 2 quarters · filed 2024-05-10
$11.09M
derived: sum of 3 quarters · filed 2024-05-10
$14.21M
derived: sum of 4 quarters · filed 2024-05-10
2023-12-31$4.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$6.98M
derived: sum of 2 quarters · filed 2024-02-28
$10.10M
derived: sum of 3 quarters · filed 2024-02-28
$14.42M
10-K · filed 2024-02-28
2023-09-30$2.86M
10-Q · filed 2023-11-09
$5.98M
derived: sum of 2 quarters · filed 2023-11-09
$10.30M
10-Q · filed 2023-11-09
$14.90M
derived: sum of 4 quarters · filed 2024-05-10
2023-06-30$3.12M
10-Q · filed 2023-08-08
$7.44M
10-Q · filed 2023-08-08
$12.04M
derived: sum of 3 quarters · filed 2024-05-10
$16.21M
derived: sum of 4 quarters · filed 2024-05-10
2023-03-31$4.32M
10-Q · filed 2024-05-10
$8.92M
derived: sum of 2 quarters · filed 2024-05-10
$13.09M
derived: sum of 3 quarters · filed 2024-05-10
$19.32M
derived: sum of 4 quarters · filed 2024-05-10
2022-12-31$4.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$8.77M
derived: sum of 2 quarters · filed 2024-02-28
$15.00M
derived: sum of 3 quarters · filed 2024-02-28
$19.88M
10-K · filed 2024-02-28
2022-09-30$4.17M
10-Q · filed 2023-11-09
$10.40M
derived: sum of 2 quarters · filed 2023-11-09
$15.28M
10-Q · filed 2023-11-09
$20.42M
derived: sum of 4 quarters · filed 2024-02-28
2022-06-30$6.23M
10-Q · filed 2023-08-08
$11.11M
10-Q · filed 2023-08-08
$16.25M
derived: sum of 3 quarters · filed 2024-02-28
$21.43M
derived: sum of 4 quarters · filed 2024-02-28
2022-03-31$4.88M
10-Q · filed 2023-05-09
$10.01M
derived: sum of 2 quarters · filed 2024-02-28
$15.20M
derived: sum of 3 quarters · filed 2024-02-28
$21.16M
derived: sum of 4 quarters · filed 2024-02-28
2021-12-31$5.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28
$10.32M
derived: sum of 2 quarters · filed 2024-02-28
$16.29M
derived: sum of 3 quarters · filed 2024-02-28
$21.13M
10-K · filed 2024-02-28
2021-09-30$5.18M
10-Q · filed 2022-11-09
$11.15M
derived: sum of 2 quarters · filed 2022-11-09
$15.99M
10-Q · filed 2022-11-09
$19.87M
derived: sum of 4 quarters · filed 2023-02-28
2021-06-30$5.97M
10-Q · filed 2022-08-09
$10.81M
10-Q · filed 2022-08-09
$14.69M
derived: sum of 3 quarters · filed 2023-02-28
$19.15M
derived: sum of 4 quarters · filed 2023-02-28
2021-03-31$4.84M
10-Q · filed 2022-05-10
$8.72M
derived: sum of 2 quarters · filed 2023-02-28
$13.18M
derived: sum of 3 quarters · filed 2023-02-28
$16.58M
derived: sum of 4 quarters · filed 2023-02-28
2020-12-31$3.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28
$8.34M
derived: sum of 2 quarters · filed 2023-02-28
$11.74M
derived: sum of 3 quarters · filed 2023-02-28
$15.14M
10-K · filed 2023-02-28
2020-09-30$4.46M
10-Q · filed 2021-11-05
$7.86M
derived: sum of 2 quarters · filed 2021-11-05
$11.27M
10-Q · filed 2021-11-05
$14.67M
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$3.40M
10-Q · filed 2021-08-05
$6.81M
10-Q · filed 2021-08-05
$10.21M
derived: sum of 3 quarters · filed 2022-03-01
$13.61M
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$3.40M
10-Q · filed 2021-05-10
$6.81M
derived: sum of 2 quarters · filed 2022-03-01
$10.21M
derived: sum of 3 quarters · filed 2022-03-01
$13.61M
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$6.81M
derived: sum of 2 quarters · filed 2022-03-01
$10.21M
derived: sum of 3 quarters · filed 2022-03-01
$13.61M
10-K · filed 2022-03-01
2019-09-30$3.40M
10-Q · filed 2020-11-10
$6.81M
derived: sum of 2 quarters · filed 2020-11-10
$10.21M
10-Q · filed 2020-11-10
$13.61M
derived: sum of 4 quarters · filed 2021-03-01
2019-06-30$3.40M
10-Q · filed 2020-08-10
$6.81M
10-Q · filed 2020-08-10
$10.21M
derived: sum of 3 quarters · filed 2021-03-01
$13.61M
derived: sum of 4 quarters · filed 2021-03-01
2019-03-31$3.40M
10-Q · filed 2020-05-11
$6.81M
derived: sum of 2 quarters · filed 2021-03-01
$10.21M
derived: sum of 3 quarters · filed 2021-03-01
$13.61M
derived: sum of 4 quarters · filed 2021-03-01
2018-12-31$3.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01
$6.81M
derived: sum of 2 quarters · filed 2021-03-01
$10.21M
derived: sum of 3 quarters · filed 2021-03-01
$13.61M
10-K · filed 2021-03-01
2018-09-30$3.40M
10-Q · filed 2019-11-07
$6.81M
derived: sum of 2 quarters · filed 2019-11-07
$10.21M
10-Q · filed 2019-11-07
$13.73M
derived: sum of 4 quarters · filed 2020-03-11
2018-06-30$3.40M
10-Q · filed 2019-08-07
$6.81M
10-Q · filed 2019-08-07
$10.33M
derived: sum of 3 quarters · filed 2020-03-11
$13.85M
derived: sum of 4 quarters · filed 2020-03-11
2018-03-31$3.40M
10-Q · filed 2019-05-02
$6.93M
derived: sum of 2 quarters · filed 2020-03-11
$10.45M
derived: sum of 3 quarters · filed 2020-03-11
$13.96M
derived: sum of 4 quarters · filed 2020-03-11
2017-12-31$3.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11
$7.04M
derived: sum of 2 quarters · filed 2020-03-11
$10.56M
derived: sum of 3 quarters · filed 2020-03-11
$14.07M
10-K · filed 2020-03-11
2017-09-30$3.52M
10-Q · filed 2018-11-07
$7.04M
derived: sum of 2 quarters · filed 2018-11-07
$10.55M
10-Q · filed 2018-11-07
$14.06M
derived: sum of 4 quarters · filed 2019-03-18
2017-06-30$3.52M
10-Q · filed 2018-08-08
$7.03M
10-Q · filed 2018-08-08
$10.54M
derived: sum of 3 quarters · filed 2019-03-18
$14.05M
derived: sum of 4 quarters · filed 2019-03-18
2017-03-31$3.51M
10-Q · filed 2018-05-09
$7.02M
derived: sum of 2 quarters · filed 2019-03-18
$10.53M
derived: sum of 3 quarters · filed 2019-03-18
$14.04M
derived: sum of 4 quarters · filed 2019-03-18
2016-12-31$3.51M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18
$7.02M
derived: sum of 2 quarters · filed 2019-03-18
$10.53M
derived: sum of 3 quarters · filed 2019-03-18
$12.96M
10-K · filed 2019-03-18
2016-09-30$3.51M
10-Q · filed 2017-11-07
$7.02M
derived: sum of 2 quarters · filed 2017-11-07
$9.46M
10-Q · filed 2017-11-07
$9.57M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$3.51M
10-Q · filed 2017-08-08
$5.95M
10-Q · filed 2017-08-08
$6.06M
derived: sum of 3 quarters · filed 2018-03-14
$6.12M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$2.43M
10-Q · filed 2017-05-08
$2.54M
derived: sum of 2 quarters · filed 2018-03-14
$2.61M
derived: sum of 3 quarters · filed 2018-03-14
$2.63M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$115.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$179.00K
derived: sum of 2 quarters · filed 2018-03-14
$205.00K
derived: sum of 3 quarters · filed 2018-03-14
$241.00K
10-K · filed 2018-03-14
2015-09-30$64.00K
10-Q · filed 2016-11-09
$90.00K
derived: sum of 2 quarters · filed 2016-11-09
$126.00K
10-Q · filed 2016-11-09
$133.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-06-30$26.00K
10-Q · filed 2016-08-09
$62.00K
10-Q · filed 2016-08-09
$69.00K
derived: sum of 3 quarters · filed 2017-02-27
$116.00K
derived: sum of 4 quarters · filed 2017-02-27
2015-03-31$36.00K
10-Q · filed 2016-05-05
$43.00K
derived: sum of 2 quarters · filed 2017-02-27
$90.00K
derived: sum of 3 quarters · filed 2017-02-27
$141.00K
derived: sum of 4 quarters · filed 2017-02-27
2014-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27
$54.00K
derived: sum of 2 quarters · filed 2017-02-27
$105.00K
derived: sum of 3 quarters · filed 2017-02-27
$157.00K
10-K · filed 2017-02-27
2014-09-30$47.00K
10-Q · filed 2015-11-09
$98.00K
derived: sum of 2 quarters · filed 2015-11-09
$150.00K
10-Q · filed 2015-11-09
$178.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-06-30$51.00K
10-Q · filed 2015-08-10
$103.00K
10-Q · filed 2015-08-10
$131.00K
derived: sum of 3 quarters · filed 2016-02-29
$195.00K
derived: sum of 4 quarters · filed 2016-02-29
2014-03-31$52.00K
10-Q · filed 2015-05-07
$80.00K
derived: sum of 2 quarters · filed 2016-02-29
$144.00K
derived: sum of 3 quarters · filed 2016-02-29
$189.00K
derived: sum of 4 quarters · filed 2016-02-29
2013-12-31$28.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29
$92.00K
derived: sum of 2 quarters · filed 2016-02-29
$137.00K
derived: sum of 3 quarters · filed 2016-02-29
$160.00K
10-K · filed 2016-02-29
2013-09-30$64.00K
10-Q · filed 2014-11-06
$109.00K
derived: sum of 2 quarters · filed 2014-11-06
$132.00K
10-Q · filed 2014-11-06
$151.00K
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$45.00K
10-Q · filed 2014-08-07
$68.00K
10-Q · filed 2014-08-07
$87.00K
derived: sum of 3 quarters · filed 2015-02-27
$93.00K
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$22.00K
10-Q · filed 2014-05-08
$42.00K
derived: sum of 2 quarters · filed 2015-02-27
$48.00K
derived: sum of 3 quarters · filed 2015-02-27
$51.00K
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$20.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$26.00K
derived: sum of 2 quarters · filed 2015-02-27
$29.00K
derived: sum of 3 quarters · filed 2015-02-27
$32.00K
10-K · filed 2015-02-27
2012-09-30$6.00K
10-Q · filed 2013-11-12
$9.00K
derived: sum of 2 quarters · filed 2013-11-12
$12.00K
10-Q · filed 2013-11-12
$15.00K
derived: sum of 4 quarters · filed 2014-03-12
2012-06-30$3.00K
10-Q · filed 2013-08-08
$6.00K
10-Q · filed 2013-08-08
$9.00K
derived: sum of 3 quarters · filed 2014-03-12
$11.00K
derived: sum of 4 quarters · filed 2014-03-12
2012-03-31$3.00K
10-Q · filed 2013-05-09
$6.00K
derived: sum of 2 quarters · filed 2014-03-12
$8.00K
derived: sum of 3 quarters · filed 2014-03-12
$10.00K
derived: sum of 4 quarters · filed 2014-03-12
2011-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12
$5.00K
derived: sum of 2 quarters · filed 2014-03-12
$7.00K
derived: sum of 3 quarters · filed 2014-03-12
$9.00K
10-K · filed 2014-03-12
2011-09-30$2.00K
10-Q · filed 2012-11-09
$4.00K
derived: sum of 2 quarters · filed 2012-11-09
$6.00K
10-Q · filed 2012-11-09
$9.00K
derived: sum of 4 quarters · filed 2013-03-12
2011-06-30$2.00K
10-Q · filed 2012-08-09
$4.00K
10-Q · filed 2012-08-09
$7.00K
derived: sum of 3 quarters · filed 2013-03-12
$9.00K
derived: sum of 4 quarters · filed 2013-03-12
2011-03-31$2.00K
10-Q · filed 2012-05-09
$5.00K
derived: sum of 2 quarters · filed 2013-03-12
$7.00K
derived: sum of 3 quarters · filed 2013-03-12
$9.00K
derived: sum of 4 quarters · filed 2013-03-12
2010-12-31$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12
$5.00K
derived: sum of 2 quarters · filed 2013-03-12
$7.00K
derived: sum of 3 quarters · filed 2013-03-12
$9.00K
10-K · filed 2013-03-12
2010-09-30$2.00K
10-Q · filed 2011-11-08
$4.00K
derived: sum of 2 quarters · filed 2011-11-08
$6.00K
10-Q · filed 2011-11-08
2010-06-30$2.00K
10-Q · filed 2011-08-09
$4.00K
10-Q · filed 2011-08-09
2009-12-31$786.00K
10-K · filed 2012-03-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16